Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q3 2024

Top Holdings415 positions

Checking export access…
Activity:

Microsoft Corp

76.4M$32.9B6.8%$117.27+261.22%
24 qtrssince 2018-Q4
Decreased
0

Facebook Inc

37.4M$21.4B4.4%$261.64+117.37%
24 qtrssince 2018-Q4
Decreased
0

Amazon.com Inc

92.6M$17.3B3.6%$115.42+61.44%
24 qtrssince 2018-Q4
Decreased
0

Apple Inc

71.4M$16.6B3.5%$173.38+33.27%
24 qtrssince 2018-Q4
Increased
61

Broadcom Inc

92.5M$16B3.3%$23.94+608.32%
24 qtrssince 2018-Q4
Increased
94

UnitedHealth Group Inc

18M$10.5B2.2%$320.06+74.16%
24 qtrssince 2018-Q4
Increased
56

Alphabet Inc

62M$10.3B2.1%$92.01+79.00%
24 qtrssince 2018-Q4
Increased
55

General Electric Co

52.6M$9.9B2.1%$56.17+231.91%
13 qtrssince 2021-Q3
Decreased
0

United Technologies Corp

79.5M$9.6B2.0%$69.71+67.89%
19 qtrssince 2020-Q1
Decreased
0

Eli Lilly & Co

9.3M$8.2B1.7%$446.09+95.86%
10 qtrssince 2022-Q2
Increased
51

Carrier Global Corp

95.2M$7.7B1.6%$34.77+125.23%
18 qtrssince 2020-Q2
Decreased
0

NVIDIA Corp

61.5M$7.5B1.6%$30.67+294.93%
8 qtrssince 2022-Q4
Decreased
0

Texas Instruments Inc

36.1M$7.5B1.5%$158.88+23.04%
24 qtrssince 2018-Q4
Increased
56

Philip Morris International In

56.3M$6.8B1.4%$59.25+90.75%
24 qtrssince 2018-Q4
Decreased
0

salesforce.com Inc

24.4M$6.7B1.4%$222.65+21.38%
8 qtrssince 2022-Q4
Increased
51

AbbVie Inc

33.2M$6.6B1.4%$103.12+79.34%
24 qtrssince 2018-Q4
Increased
50

Alphabet Inc

38.9M$6.5B1.4%$78.44+111.67%
24 qtrssince 2018-Q4
Decreased
0

Abbott Laboratories

53.3M$6.1B1.3%$67.55+61.85%
24 qtrssince 2018-Q4
Decreased
0

Mastercard Inc

12.2M$6B1.3%$255.89+90.68%
24 qtrssince 2018-Q4
Decreased
0

GE HealthCare Technologies Inc

58.2M$5.5B1.1%$82.50+13.35%
7 qtrssince 2023-Q1
Increased
54
$481.1B
AUM
415
Positions
Q3 2024
Filing
HI score · 4.0/5
Quarterly 13F Value Change
+7%Q2'23$373.2B-3%Q3'23$363.2B+12%Q4'23$406.5B+9%Q1'24$442B+3%Q2'24$455.7B+6%Q3'24$481.1B
Activity profile
$ moved · Q3'24
New6%Increased50%Decreased39%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.7 years
<1Q6%1-4Q12%1-2Y10%2Y+72%

Capital Research Global Investors manages $481.1B across 415 positions as of Q3 2024. Top holdings: MSFT (6.8%), META (4.4%), AMZN (3.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q3 2024 Summary

Active quarter - 35 new positions, 34 exits, 185 increased. Top move: AVGO (INCREASED, conviction 94). Portfolio: $481.1B across 415 positions.

Top holdings by portfolio weight

Total AUM$481B
MSFT6.83%
META4.45%
AMZN3.59%
AAPL3.46%
AVGO3.32%
UNH2.19%
GOOGL2.14%
GE2.06%
RTX2.00%
LLY1.71%
Other1.59%

Portfolio allocation by GICS sector

Sectors11
Technology25.07%
Healthcare15.53%
Consumer Cyclical13.12%
Industrials12.38%
Communication Services9.37%
Financial Services8.92%
Consumer Defensive3.71%
Basic Materials3.69%
Energy3.65%
Utilities2.92%
Other1.63%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used